Dr. Datsons Labs Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 14	Mar ' 13	Mar ' 12	Mar ' 11	Mar ' 10

Sources of funds

Owner's fund

Equity share capital

31.66

13.89

13.89

7.58

5.78

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

376.21

295.58

335.91

126.81

44.00

Loan funds

Secured loans

215.99

179.76

193.94

123.35

49.59

Unsecured loans

159.13

370.27

104.64

15.50

10.10

Total

782.98

859.50

648.39

273.23

109.47

Uses of funds

Fixed assets

Gross block

248.82

248.55

233.72

74.55

48.55

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

60.53

40.09

19.87

4.21

1.62

Net block

188.29

208.46

213.85

70.35

46.93

Capital work-in-progress

179.01

164.09

144.24

46.68

4.20

Investments

212.78

2.40

0.78

0.05

0.05

Net current assets

Current assets, loans & advances

682.81

670.07

359.08

177.80

83.58

Less : current liabilities & provisions

479.91

185.52

69.56

21.65

25.30

Total net current assets

202.90

484.55

289.52

156.15

58.29

Miscellaneous expenses not written

-

-

-

-

-

Total

782.98

859.50

648.39

273.23

109.47

Notes:

Book value of unquoted investments

212.78

2.40

0.78

0.05

0.05

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

0.82

-

-

-

-

Number of equity sharesoutstanding (Lacs)

316.55

138.87

138.87

75.77

57.77